Investors

STOUGHTON, Mass., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences in December:

• The Piper Jaffray 31^st Annual Healthcare Conference on Tuesday, December 3^rd in New York City. Management will present at 2:30 p.m. ET and will also participate in investor meetings.  
   
• The Jefferies Biopharma Summit on Thursday, December 12^th in Denver. Management will participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
adasalla@collegiumpharma.com

Source: Collegium Pharmaceutical, Inc.